Homestead Advisers’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $69.9M | Buy |
1,939,440
+8,300
| +0.4% | +$299K | 1.66% | 29 |
|
|
2025
Q1 | $60.1M | Hold |
1,931,140
| – | – | 1.47% | 35 |
|
|
2024
Q4 | $49.3M | Buy |
1,931,140
+73,000
| +4% | +$1.86M | 1.19% | 41 |
|
|
2024
Q3 | $52.6M | Sell |
1,858,140
-1,800
| -0.1% | -$50.9K | 1.25% | 40 |
|
|
2024
Q2 | $49M | Sell |
1,859,940
-32,600
| -2% | -$860K | 1.21% | 39 |
|
|
2024
Q1 | $57.5M | Buy |
1,892,540
+547,000
| +41% | +$16.6M | 1.35% | 35 |
|
|
2023
Q4 | $37.8M | Buy |
1,345,540
+2,500
| +0.2% | +$70.2K | 0.97% | 42 |
|
|
2023
Q3 | $36.5M | Buy |
1,343,040
+21,000
| +2% | +$570K | 1.01% | 41 |
|
|
2023
Q2 | $40.6M | Buy |
1,322,040
+6,700
| +0.5% | +$206K | 1.08% | 37 |
|
|
2023
Q1 | $47.4M | Sell |
1,315,340
-28,400
| -2% | -$1.02M | 1.32% | 34 |
|
|
2022
Q4 | $53.1M | Buy |
1,343,740
+400
| +0% | +$15.8K | 1.42% | 34 |
|
|
2022
Q3 | $54M | Sell |
1,343,340
-3,200
| -0.2% | -$129K | 1.63% | 30 |
|
|
2022
Q2 | $56.6M | Hold |
1,346,540
| – | – | 1.6% | 28 |
|
|
2022
Q1 | $52.5M | Sell |
1,346,540
-21,000
| -2% | -$818K | 1.28% | 35 |
|
|
2021
Q4 | $54.5M | Buy |
1,367,540
+209,700
| +18% | +$8.36M | 1.25% | 35 |
|
|
2021
Q3 | $41.8M | Buy |
1,157,840
+437,600
| +61% | +$15.8M | 1.02% | 43 |
|
|
2021
Q2 | $29.5M | Buy |
+720,240
| New | +$29.5M | 0.68% | 50 |
|